Teva Pharma (TEVA) shares of pharma name closed green on Thursday in a ugly tape after it reported a strong quarter this week and seeing a bullish MACD cross pointing to new highs likely as it tries to clear above this 17.50 resistance from a coiled 3 month range. TEVA can see a quick move to 18.50 as a first target while 20.00 is likely a longer-term move in the next few months. Recent opening sales of 15,000 September $16 puts at $0.82 are still holding in OI and this week saw buyers of over 6000 December $21 calls at $0.72.